Queen Mary University of London researchers announce ground-breaking clinical trial ...
Researchers from Queen Mary University of London presented findings at the ESMO Congress 2024, showing that chemotherapy-immunotherapy combinations improve survival in triple-negative breast cancer and muscle-invasive bladder cancer, becoming new standards of care.
Reference News
Queen Mary University of London researchers announce ground-breaking clinical trial ...
Researchers from Queen Mary University of London presented findings at the ESMO Congress 2024, showing that chemotherapy-immunotherapy combinations improve survival in triple-negative breast cancer and muscle-invasive bladder cancer, becoming new standards of care.